Intravitreal aflibercept for proliferative diabetic retinopathy - Authors' reply.
Sivaprasad, Sobha
Intravitreal aflibercept for proliferative diabetic retinopathy - Authors' reply. [electronic resource] - Lancet (London, England) 11 2017 - 2141-2142 p. digital
Publication Type: Letter; Comment
1474-547X
10.1016/S0140-6736(17)32422-4 doi
Angiogenesis Inhibitors
Bevacizumab
Diabetic Retinopathy
Humans
Receptors, Vascular Endothelial Growth Factor
Recombinant Fusion Proteins
Vascular Endothelial Growth Factor A
Intravitreal aflibercept for proliferative diabetic retinopathy - Authors' reply. [electronic resource] - Lancet (London, England) 11 2017 - 2141-2142 p. digital
Publication Type: Letter; Comment
1474-547X
10.1016/S0140-6736(17)32422-4 doi
Angiogenesis Inhibitors
Bevacizumab
Diabetic Retinopathy
Humans
Receptors, Vascular Endothelial Growth Factor
Recombinant Fusion Proteins
Vascular Endothelial Growth Factor A